To Evaluate the Efficacy of Methylene Blue in Identification of Neck Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma
- PMID: 39902426
- PMCID: PMC11787064
- DOI: 10.1007/s12663-024-02425-9
To Evaluate the Efficacy of Methylene Blue in Identification of Neck Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma
Abstract
Background: Sentinel lymph node is the first lymph node to drain a metastatic tumor cell or cluster of cells that drains via the lymphatic route. Mapping from the tumor site to the regional lymphatic drainage area can be used to identify the primary draining lymph node. The status of the sentinel node decides the need for neck dissection. The purpose of this study is to evaluate the efficacy of Methylene blue in identification of Neck Sentinel Lymph Nodes (SLN) in oral squamous cell carcinoma. A total of 10 patients diagnosed histopathologically with oral squamous cell carcinoma were included in the study. Efficacy of methylene blue intraoperatively as an injectable medium for sentinel lymph node biopsy is established.
Results: SLN were identified in all the 10 cases, with an average of 1.8 SLN per patient and standard deviation of 1.13.
Conclusion: We conclude that, methylene blue is an effective, hypoallergenic, low cost and easily available dye that has shown promising results in identification of sentinel lymph nodes in early oral cancer, signifying the important role to be played by SLNB procedures in deciding the type of neck dissection with least morbidity and maximum outcome.
Keywords: Methylene blue; Oral cancer; Sentinel lymph node (SLN); Sentinel lymph node biopsy (SLNB).
© The Association of Oral and Maxillofacial Surgeons of India 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Similar articles
-
A Prospective Cohort Study on Neck Lymph Node Mapping in Oral Cancers Using Methylene Blue Dye.Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3330-3337. doi: 10.1007/s12070-024-04682-z. Epub 2024 Apr 16. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 39130243 Free PMC article.
-
Sentinel Lymph Node Biopsy Evaluation in Early Stage T1, T2, N0, Squamous Cell Carcinoma of the Oral Cavity with Methylene Blue Dye.Indian J Surg Oncol. 2025 Feb;16(1):245-250. doi: 10.1007/s13193-024-02078-7. Epub 2024 Aug 28. Indian J Surg Oncol. 2025. PMID: 40114874
-
Sentinel Lymph Node Biopsy in Cutaneous Melanoma: Standard and New Technical Procedures and Clinical Advances. A Systematic Review of the Literature.Clin Nucl Med. 2016 Dec;41(12):e498-e507. doi: 10.1097/RLU.0000000000001370. Clin Nucl Med. 2016. PMID: 27749418
-
[18F]FDG PET/CT to reduce the need for sentinel lymph node biopsy in early-stage oral cancer: PETN0-study protocol.PLoS One. 2025 Jul 1;20(7):e0325032. doi: 10.1371/journal.pone.0325032. eCollection 2025. PLoS One. 2025. PMID: 40591621 Free PMC article.
-
Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature.Dermatol Surg. 2006 Nov;32(11):1309-21. doi: 10.1111/j.1524-4725.2006.32300.x. Dermatol Surg. 2006. PMID: 17083582
References
-
- Yanamoto S, Yamada S, Takahashi H, Yoshitomi I, Kawasaki G et al (2012) Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 41:1195–1200. 10.1016/2012.07.011 - PubMed